Dobesel Tablets 500 mg (Dobesilic Acid Calcium Hydrate)

Adult dose

Adults: Administer the following doses of calcium dobesilate hydrate orally. 1. Vascular damage and retinopathy: 500~1000mg daily 2. Venous disorders: Administer 750mg daily for 1~3 weeks, then 500mg daily thereafter. Administer after meals with plenty of fluids. Adjust the dose as appropriate according to age and symptoms.

This medication contains Dobesilic Acid Calcium Hydrate as its active ingredient and should not be used by certain patients. First, individuals allergic to this medication or its components should not take it. Additionally, pregnant or nursing women should not use this medication. Since this medication contains lactose, individuals with lactose intolerance or specific genetic metabolic disorders should avoid taking it. Its safety and efficacy have not been fully verified for patients with impaired renal function, so it should be used with caution, and in particular, the dosage may need to be reduced in patients with severe renal failure. Patients with impaired liver function also need to use this medication carefully, and if there is an increase in liver enzyme levels, treatment should be reassessed. This medication contains sulfite, which may cause allergic reactions or severe asthma attacks in some sensitive individuals, especially asthmatics. Common side effects during treatment may include headaches, abdominal pain, nausea, diarrhea, vomiting, joint pain, and muscle pain. Allergic reactions such as skin rash, itching, urticaria, and facial swelling may occur rarely, and in severe cases, life-threatening reactions such as anaphylaxis may occur. If symptoms of infection such as high fever, sore throat, or oral infections develop during treatment, notify a doctor immediately, and check the condition through blood tests and discontinue medication if necessary. If hypersensitivity is suspected, stop the medication immediately and consult a healthcare professional. There are no known interactions with other medications, but since it may affect blood test results, inform the healthcare professional about this before undergoing tests.

• Agranulocytosis
• neutropenia
• leukopenia
• hypersensitivity reactions
• skin rash
• allergic dermatitis
• itching
• urticaria
• facial swelling
• anaphylaxis

This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is best stored at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness.

Appearance

White oblong tablet

Package unit

30 tablets/bottle, 90 tablets/bottle